BENITEC BIOPHARMA INC. (BNTC) Operating margin 2019–2023
BENITEC BIOPHARMA INC. (BNTC) operating margin by fiscal year — reported operating income divided by reported revenue.
-25441.3%FY2023 · since FY2019: 21.2% → -25441.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -25441.3% | -983.8 pp |
| FY2022 | -24457.5% | -1413.5 pp |
| FY2021 | -23044.1% | -14925.4 pp |
| FY2020 | -8118.6% | -8139.8 pp |
| FY2019 | 21.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BNTC financial trends
BNTC RevenueBNTC Net incomeBNTC Net marginBNTC Gross profitBNTC Gross marginBNTC Operating incomeBNTC Operating cash flowBNTC Free cash flowBNTC Capital expendituresBNTC Return on equityBNTC Stock buybacksBNTC Dividends paidBNTC Total assetsBNTC Total liabilitiesBNTC Shareholders’ equityBNTC overview →